Nuvation Bio Completes Acquisition of AnHeart TherapeuticsNuvation Bio Inc. (NYSE: NUVB), a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates...
Business Wire•4 months ago